178 related articles for article (PubMed ID: 9738976)
21. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.
Thompson AD; Braun BS; Arvand A; Stewart SD; May WA; Chen E; Korenberg J; Denny C
Oncogene; 1996 Dec; 13(12):2649-58. PubMed ID: 9000139
[TBL] [Abstract][Full Text] [Related]
22. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
Leacock SW; Basse AN; Chandler GL; Kirk AM; Rakheja D; Amatruda JF
Dis Model Mech; 2012 Jan; 5(1):95-106. PubMed ID: 21979944
[TBL] [Abstract][Full Text] [Related]
23. EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.
Kinsey M; Smith R; Iyer AK; McCabe ER; Lessnick SL
Cancer Res; 2009 Dec; 69(23):9047-55. PubMed ID: 19920188
[TBL] [Abstract][Full Text] [Related]
24. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
[TBL] [Abstract][Full Text] [Related]
25. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.
Ouchida M; Ohno T; Fujimura Y; Rao VN; Reddy ES
Oncogene; 1995 Sep; 11(6):1049-54. PubMed ID: 7566963
[TBL] [Abstract][Full Text] [Related]
26. In situ reverse-transcriptase polymerase chain reaction demonstration of the EWS/FLI-1 fusion transcript in Ewing's sarcomas and peripheral primitive neuroectodermal tumors.
Krams M; Peters J; Boeckel F; Raether A; Ambros PF; Parwaresch R; Harms D
Virchows Arch; 2000 Sep; 437(3):234-40. PubMed ID: 11037342
[TBL] [Abstract][Full Text] [Related]
27. Mutant screening for oncogenes of Ewing's sarcoma using yeast.
Kitagawa T; Okita H; Baron B; Tokuda K; Nakamura M; Wang Y; Akada J; Hoshida H; Akada R; Kuramitsu Y; Nakamura K
Appl Microbiol Biotechnol; 2015 Aug; 99(16):6737-44. PubMed ID: 25936378
[TBL] [Abstract][Full Text] [Related]
28. Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor.
May WA; Denny CT
Curr Top Microbiol Immunol; 1997; 220():143-50. PubMed ID: 9103680
[No Abstract] [Full Text] [Related]
29. Treatment of Ewing's sarcoma using an antisense oligodeoxynucleotide to regulate the cell cycle.
Asami S; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
Biol Pharm Bull; 2008 Mar; 31(3):391-4. PubMed ID: 18310898
[TBL] [Abstract][Full Text] [Related]
30. A method for accurate detection of translocation junctions in Ewing family of tumors.
Morishita T; Bolander ME; Zhang K; Tamai S; Mii Y; Sarkar G
Mol Biotechnol; 2001 Jun; 18(2):97-104. PubMed ID: 11471459
[TBL] [Abstract][Full Text] [Related]
31. Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway.
Spahn L; Petermann R; Siligan C; Schmid JA; Aryee DN; Kovar H
Cancer Res; 2002 Aug; 62(16):4583-7. PubMed ID: 12183411
[TBL] [Abstract][Full Text] [Related]
32. Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma.
Ban J; Jug G; Mestdagh P; Schwentner R; Kauer M; Aryee DN; Schaefer KL; Nakatani F; Scotlandi K; Reiter M; Strunk D; Speleman F; Vandesompele J; Kovar H
Oncogene; 2011 May; 30(18):2173-80. PubMed ID: 21217773
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic significance and clinical applications of chimeric genes in Ewing's sarcoma.
Yoshino N; Kojima T; Asami S; Motohashi S; Yoshida Y; Chin M; Shichino H; Yoshida Y; Nemoto N; Kaneko M; Mugishima H; Suzuki T
Biol Pharm Bull; 2003 May; 26(5):585-8. PubMed ID: 12736494
[TBL] [Abstract][Full Text] [Related]
34. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
Lessnick SL; Braun BS; Denny CT; May WA
Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
[TBL] [Abstract][Full Text] [Related]
35. An EWS/ERG fusion with a truncated N-terminal domain of EWS in a Ewing's tumor.
Peter M; Mugneret F; Aurias A; Thomas G; Magdelenat H; Delattre O
Int J Cancer; 1996 Jul; 67(3):339-42. PubMed ID: 8707406
[TBL] [Abstract][Full Text] [Related]
36. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
[TBL] [Abstract][Full Text] [Related]
37. [Ewing's tumours, genetic and cellular aspects].
Delattre O
Pathol Biol (Paris); 2008 Jul; 56(5):257-9. PubMed ID: 18485618
[TBL] [Abstract][Full Text] [Related]
38. EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts.
Teitell MA; Thompson AD; Sorensen PH; Shimada H; Triche TJ; Denny CT
Lab Invest; 1999 Dec; 79(12):1535-43. PubMed ID: 10616204
[TBL] [Abstract][Full Text] [Related]
39. Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift.
Bridge JA; Fidler ME; Neff JR; Degenhardt J; Wang M; Walker C; Dorfman HD; Baker KS; Seemayer TA
Am J Surg Pathol; 1999 Feb; 23(2):159-65. PubMed ID: 9989842
[TBL] [Abstract][Full Text] [Related]
40. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.
Smith R; Owen LA; Trem DJ; Wong JS; Whangbo JS; Golub TR; Lessnick SL
Cancer Cell; 2006 May; 9(5):405-16. PubMed ID: 16697960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]